Literature DB >> 31937110

An improved Xer-cise technology for the generation of multiple unmarked mutants in Mycobacteria.

Yves-Marie Boudehen1, Maximilian Wallat1, Philippe Rousseau2, Olivier Neyrolles1, Claude Gutierrez1.   

Abstract

Xer-cise is a technique using antibiotic resistance cassettes flanked by dif sites allowing spontaneous and accurate excision from bacterial chromosomes with a high frequency through the action of the cellular recombinase XerCD. Here, we report a significant improvement of Xer-cise in Mycobacteria. Zeocin resistance cassettes flanked by variants of the natural Mycobacterium tuberculosis dif site were constructed and shown to be effective tools to construct multiple unmarked mutations in M. tuberculosis and in the model species Mycobacterium smegmatis. The dif site variants harbor mutations in the central region and can therefore not recombine with the wild-type or other variants, resulting in mutants of increased genetic stability. The herein described method should be generalizable to virtually any transformable bacterial species.

Entities:  

Keywords:  Mycobacterium; Xer-cise; dif site; excisable cassette; mutagenesis; recombineering; unmarked deletions

Mesh:

Year:  2020        PMID: 31937110     DOI: 10.2144/btn-2019-0119

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  3 in total

1.  Mycobacterial resistance to zinc poisoning requires assembly of P-ATPase-containing membrane metal efflux platforms.

Authors:  Yves-Marie Boudehen; Marion Faucher; Xavier Maréchal; Roger Miras; Jérôme Rech; Yoann Rombouts; Olivier Sénèque; Maximilian Wallat; Pascal Demange; Jean-Yves Bouet; Olivier Saurel; Patrice Catty; Claude Gutierrez; Olivier Neyrolles
Journal:  Nat Commun       Date:  2022-08-12       Impact factor: 17.694

2.  A nucleotidyltransferase toxin inhibits growth of Mycobacterium tuberculosis through inactivation of tRNA acceptor stems.

Authors:  Yiming Cai; Ben Usher; Claude Gutierrez; Anastasia Tolcan; Moise Mansour; Peter C Fineran; Ciarán Condon; Olivier Neyrolles; Pierre Genevaux; Tim R Blower
Journal:  Sci Adv       Date:  2020-07-29       Impact factor: 14.136

3.  Engineering a Novel Bivalent Oral Vaccine against Enteric Fever.

Authors:  Annelise Soulier; Claudia Prevosto; Mary Chol; Livija Deban; Rocky M Cranenburgh
Journal:  Int J Mol Sci       Date:  2021-03-23       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.